Pharmacology, Toxicology and Pharmaceutical Science
Intermedin
100%
Melanocortin Receptor
70%
Arginine
45%
Receptor
32%
Amino Acid
29%
Melanocortin
29%
Melanocortin 1 Receptor
28%
Melanocortin 5 Receptor
25%
Melanocortin 3 Receptor
23%
IC50
21%
Melanoma
17%
Melanocortin 4 Receptor
16%
Agonist-Antagonist
15%
Receptor Subtype
14%
Peptidomimetic Agent
13%
Opiate Receptor
13%
N Acetyl Alpha intermedin[4-10]cyclo[4 Norleucine 5 Aspartic Acid 7 [3 (2 Naphthyl)alanine] 10 Lysinamide]
13%
Receptor Antagonist
11%
Drug Development
11%
Tetrapeptide
11%
Proopiomelanocortin
11%
Biological Activity
10%
G Protein Coupled Receptor
9%
EC50
9%
Lactam
9%
Macrocyclic Compound
8%
Degenerative Disease
8%
Blood-Brain Barrier
8%
Feeding Disorder
7%
Cysteine
6%
Structure Activity Relationship
6%
Mouse
6%
Endothelial Dysfunction
5%
Nitric Oxide
5%
Proline Derivative
5%
2,5-Dimethoxy-4-iodoamphetamine
5%
Disease
5%
Helianthus annuus
5%
Laser-Fluorescence Microscopy
5%
Aromatic Amino Acid
5%
Ether
5%
Drug Conjugate
5%
Pharmaceutical Chemistry
5%
Polypeptide
5%
Toll Like Receptor 2
5%
Agouti Related Protein
5%
Laser Microscopy
5%
Pharmacological Activity
5%
Side Effect
5%
Lactam Derivative
5%
Biochemistry, Genetics and Molecular Biology
Melanocortin Receptor
85%
Melanocyte-Stimulating Hormone
75%
Agonist
56%
Eicosanoid Receptor
42%
Melanocortin 4 Receptor
41%
Amino Acids
34%
Melanocortin 3 Receptor
34%
Melanocortin
27%
Melanocortin 5 Receptor
24%
Binding Affinity
21%
Pharmacophore
20%
IC50
18%
Melanocortin 1 Receptor
15%
Methylation
15%
EC50
13%
Receptor Antagonist
12%
Cyclic Peptide
11%
Tetrapeptide
10%
G Protein Coupled Receptor
9%
Conformation
9%
Adrenocorticotropic Hormone
9%
Melanotan II
8%
C-Terminus
8%
Proopiomelanocortin
7%
Pigmentation
7%
Transmembrane Domain
7%
Receptor Agonists
6%
Solid
6%
N-Terminus
6%
Cyclization
6%
Biological Functions
5%
Rigidity
5%
Bile Acid Metabolism
5%
Trypsin Inhibitor
5%
Physical Activity
5%
Laser-Fluorescence Microscopy
5%
Anura
5%
Energy Expenditure
5%
Laser Microscopy
5%
Superagonist
5%
Hormone Binding
5%
Helianthus annuus
5%
Agouti
5%
Structure Activity Relation
5%
Keyphrases
Melanocortin 1 Receptor (MC1R)
61%
Melanocortin-3 Receptor
25%
Melanocortin 4 Receptor (MC4R)
24%
Melanocortin
22%
Selective Ligands
19%
MC3R
19%
Selective Agonist
19%
Synthetic Evaluation
17%
α-Melanocyte-stimulating Hormone (α-MSH)
15%
Selective Antagonist
13%
Receptor Subtypes
12%
Pharmacophore
12%
MT II
11%
Biological Evaluation
11%
Design Evaluation
11%
Disorder Problem
11%
Pigmentation
9%
Tetrapeptide
9%
Energy Homeostasis
8%
Receptor Selectivity
7%
Highly Selective
7%
Conformational Constraint
7%
Obesity Treatment
7%
MC5R
7%
Conformational Study
7%
Core Sequence
6%
G Protein-coupled Receptor
6%
Proopiomelanocortin
6%
Hormone Signaling
5%
Disorder Potential
5%
Cognitive Function
5%
Frog Skin Peptide
5%
Addiction
5%
Pam2Cys
5%
Cysteine Analog
5%
Early Melanoma Diagnosis
5%
Hybrid Analog
5%
Pharmacology
5%
Age-related Decline
5%
Structure-activity Studies
5%
Proline Derivatives
5%
Hormone Binding
5%
Peptide Ligand
5%
Peptide Discovery
5%
Selective Affinity
5%
Sunflower Trypsin Inhibitor
5%
Microwave Synthesis
5%
Biological Studies
5%
Laser Microscopy
5%
POMC Neurons
5%
